Market Analysis

All Reports

Browse our comprehensive collection of market intelligence reports.

Healthcare|March 2020

Hyperoxaluria Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Hyperoxaluria Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments Hyperoxaluria Pipeline Analysis report covers 6 drugs currently in different phases of development. Hyperoxaluria is a disease which occurs when there is excessive oxalate present in the urine. Oxalate is naturally present in the body and in certain foods but too much oxalate may lead to complications such as kidney stones. T

Healthcare|March 2020

Neurofibromatosis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Neurofibromatosis Pipeline Analysis report covers 15 drugs currently in different phases of development. Neurofibromatosis is a genetic disorder characterised by formation of tumors on nerve tissue. There are 3 main types of neurofibromatosis: Neurofibromatosis type 1 (NF1), Neurofibromatosis type 2 (NF2) and Schwannomatosis. Neurofibromatosis type 1 (NF1) is the most common type of neurofibromatosis followed by NF2 and Schwannomatosis. Symptoms of the disease includes pr

Healthcare|March 2020

Adenoid Cystic Carcinoma Pipeline Analysis 2019 (H1)

Adenoid Cystic Carcinoma Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Adenoid cystic carcinoma (ACC) is a rare form of adenocarcinoma which occurs in the secretory glands, most common ones include the major and minor salivary glands of neck and head. It can occur in other locations of the body as

Healthcare|March 2020

Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Acromegaly Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Acromegaly Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Acromegaly is a rare hormonal disorder where there is an excess amount of growth hormone (GH) in the human body leading to the formation of enlarged bone structure and children can grow to abnormal heights. Physical chang

Healthcare|March 2020

Acquired Haemophilia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Acquired Haemophilia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Acquired Haemophilia Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Acquired haemophilia is an autoimmune rare bleeding disorder caused when a person’s own body produces antibodies which attack the blood clotting factors mostly factor VIII. In normal condition, c

Healthcare|March 2020

Achondroplasia Pipeline Analysis 2019 (H1)

Achondroplasia Pipeline Analysis report covers drugs of 6 companies currently in different phases of development. Achondroplasia is a bone growth disorder which is caused by a mutation in the FGFR3 gene. It is normally observed that during early fetal development, most of the skeleton is made up of cartilage which eventually changes into bone. In a

Healthcare|March 2020

Achalasia Pipeline Analysis 2019 (H1)

Achalasia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Achalasia Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Achalasia is a rare diseased condition where the lower esophageal sphincter (LES) muscle fails to fun

Healthcare|March 2020

Paroxysmal Nocturnal Haemoglobinuria (PNH) Pipeline Analysis 2019 (H1)

Paroxysmal Nocturnal Haemoglobinuria (PNH) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Paroxysmal Nocturnal Haemoglobinuria (PNH) Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Paroxysmal Nocturnal Haemoglobinuri

Healthcare|March 2020

Liposarcoma Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Liposarcoma Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Liposarcoma Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Liposarcoma is a malignancy of fat cells and its exact cause is however unknown. In adults, it is known as soft tissue carcinoma and can occu

Healthcare|March 2020

Neuromyelitis Optica Spectrum Disorder (NMOSD) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Neuromyelitis Optica Spectrum Disorder (NMOSD) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Neuromyelitis Optica Spectrum Disorder (NMOSD) Pipeline Analysis report covers 17 drugs currently in different phases of development. Neuromyelitis Optica Spectrum Disorder is a rare relapsing autoimmune disorder that most commonly affects optic nerves and the spinal cord, l

Healthcare|March 2020

Systemic Mastocytosis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Systemic Mastocytosis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Systemic Mastocytosis Pipeline Analysis report covers 6 drugs currently in different phases of development. Systemic mastocytosis, also known as systemic mast cell disease (SMCD) is a disorder in which mast cells accumulate in multiple organs inc

Healthcare|March 2020

Polycystic kidney disease (PKD) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

Polycystic kidney disease (PKD) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Polycystic kidney disease (PKD) Pipeline Analysis report covers 15 drugs currently in different phases of development. Polycystic kidney disease is an inherited kidney disorder characterised by formation of fluid filled cysts within the